Instituto De Oftalmología Fundación Conde De Valenciana
Clinical trials sponsored by Instituto De Oftalmología Fundación Conde De Valenciana, explained in plain language.
-
New eye drops aim to calm Sjögren's dry eye by blocking inflammation
Disease control Not yet recruitingThis phase 2 trial tests whether eye drops containing infliximab, a drug that blocks a key inflammatory protein, can safely improve severe dry eye in people with Sjögren's syndrome. 38 adults will receive either the active drops or a steroid drop for 6 weeks. The study measures s…
Phase: PHASE2 • Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Immune cell study may unlock clues to better allergy eye treatments
Knowledge-focused Not yet recruitingThis study examines immune cells in 60 people with allergic conjunctivitis, both those receiving desensitization therapy and those not, plus healthy controls. Researchers will analyze blood and tear samples to measure specific immune markers and cell activity. The goal is to find…
Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:33 UTC